JP2022502501A5 - - Google Patents
Info
- Publication number
- JP2022502501A5 JP2022502501A5 JP2021540398A JP2021540398A JP2022502501A5 JP 2022502501 A5 JP2022502501 A5 JP 2022502501A5 JP 2021540398 A JP2021540398 A JP 2021540398A JP 2021540398 A JP2021540398 A JP 2021540398A JP 2022502501 A5 JP2022502501 A5 JP 2022502501A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- formula
- phenyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024082290A JP2024109735A (ja) | 2018-09-25 | 2024-05-21 | 新規使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862736324P | 2018-09-25 | 2018-09-25 | |
| US62/736,324 | 2018-09-25 | ||
| PCT/US2019/053032 WO2020069043A1 (en) | 2018-09-25 | 2019-09-25 | Novel uses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024082290A Division JP2024109735A (ja) | 2018-09-25 | 2024-05-21 | 新規使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022502501A JP2022502501A (ja) | 2022-01-11 |
| JP2022502501A5 true JP2022502501A5 (enExample) | 2022-10-04 |
Family
ID=69953335
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540398A Pending JP2022502501A (ja) | 2018-09-25 | 2019-09-25 | 新規使用 |
| JP2024082290A Pending JP2024109735A (ja) | 2018-09-25 | 2024-05-21 | 新規使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024082290A Pending JP2024109735A (ja) | 2018-09-25 | 2024-05-21 | 新規使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20210338679A1 (enExample) |
| EP (1) | EP3856191A4 (enExample) |
| JP (2) | JP2022502501A (enExample) |
| WO (1) | WO2020069043A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020146384A1 (en) | 2019-01-07 | 2020-07-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20220054853A (ko) | 2019-09-03 | 2022-05-03 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치료 방법 |
| WO2021127517A1 (en) * | 2019-12-18 | 2021-06-24 | Intra-Cellular Therapies, Inc. | Novel uses |
| US12364695B2 (en) | 2020-06-02 | 2025-07-22 | Intra-Cellular Therapies, Inc. | Methods of treating inflammatory disease |
| WO2025212780A1 (en) * | 2024-04-02 | 2025-10-09 | Intra-Cellular Therapies, Inc. | Organic compounds |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006255028B2 (en) | 2005-06-06 | 2012-04-19 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20090042227A (ko) | 2006-06-06 | 2009-04-29 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| KR20120012831A (ko) | 2007-12-06 | 2012-02-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| EP2240028B1 (en) | 2007-12-06 | 2016-07-20 | Intra-Cellular Therapies, Inc. | Pyrazolopyrimidine-4,6-dione derivatives and their use as pharmaceutical |
| BRPI0922809A2 (pt) | 2008-12-06 | 2018-05-29 | Intracellular Therapies Inc | compostos orgânicos |
| EP2367431B1 (en) | 2008-12-06 | 2015-08-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
| EP2367430B1 (en) | 2008-12-06 | 2014-08-13 | Intra-Cellular Therapies, Inc. | Organic compounds |
| JP5778582B2 (ja) | 2008-12-06 | 2015-09-16 | イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． | 有機化合物 |
| MA32942B1 (fr) | 2008-12-06 | 2012-01-02 | Intra Cellular Therapies Inc | Composes organiques |
| CA2796756A1 (en) | 2010-04-22 | 2011-10-27 | Intra-Cellular Therapies, Inc. | Substituted pyrido(3',4':4,5)pyrrolo(1,2,3-de)quinoxalines for the treatment of central nervous system disorders |
| EP2576551A4 (en) | 2010-05-31 | 2014-04-16 | Intra Cellular Therapies Inc | ORGANIC CONNECTIONS |
| WO2011153135A1 (en) | 2010-05-31 | 2011-12-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| TW201206937A (en) | 2010-05-31 | 2012-02-16 | Intra Cellular Therapies Inc | Organic compounds |
| WO2011153136A1 (en) | 2010-05-31 | 2011-12-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US9308213B2 (en) * | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US10695431B2 (en) * | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| WO2013138118A1 (en) * | 2012-03-14 | 2013-09-19 | The Regents Of The University Of California | Treatment of inflammatory disorders in non-human mammals |
| KR102240326B1 (ko) | 2013-03-15 | 2021-04-13 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| JP7134168B6 (ja) * | 2016-09-12 | 2024-02-02 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 新規使用 |
-
2019
- 2019-09-25 US US17/279,518 patent/US20210338679A1/en active Pending
- 2019-09-25 EP EP19864482.5A patent/EP3856191A4/en active Pending
- 2019-09-25 WO PCT/US2019/053032 patent/WO2020069043A1/en not_active Ceased
- 2019-09-25 JP JP2021540398A patent/JP2022502501A/ja active Pending
-
2024
- 2024-05-21 JP JP2024082290A patent/JP2024109735A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022502501A5 (enExample) | ||
| JP2019531320A5 (enExample) | ||
| JP2024517942A5 (enExample) | ||
| RU2001111875A (ru) | Омепразол формы А, способ его получения, фармацевтиченский препарат на его основе и способ лечения желудочно-кишечных расстройств | |
| JP2007533722A5 (enExample) | ||
| RU2002107203A (ru) | Производные N-гетероциклических соединений в качестве ингибиторов синтазы оксида азота (nos) | |
| JP2016534063A (ja) | クロモリン誘導体ならびに関連するイメージングおよび治療方法 | |
| JP2010522710A5 (enExample) | ||
| JPH039900B2 (enExample) | ||
| JP2007508386A5 (enExample) | ||
| BRPI0415873A (pt) | métodos de uso de antagonistas do receptor de trombina | |
| JPH0920659A5 (enExample) | ||
| RU2005106356A (ru) | Новое соединение | |
| JP2006504738A5 (enExample) | ||
| RU2005106355A (ru) | Новое соединение | |
| JP2004532894A5 (enExample) | ||
| JP2022502501A (ja) | 新規使用 | |
| JP2024524273A5 (enExample) | ||
| JP2022536160A5 (enExample) | ||
| JP2024521127A5 (enExample) | ||
| JP2010504321A5 (enExample) | ||
| JP2021520394A5 (enExample) | ||
| WO2002083167A3 (en) | Therapeutic compositions for the treatment of a respiratory tract disease | |
| JP2553170B2 (ja) | 置換ジカルボン酸−ビス（３，５，−ジカルバモイル−２，４，６，−トリヨード−アニリド）、その製法およびこの化合物を含有するレントゲン造影剤 | |
| IL310383A (en) | DP antagonist |